Retention time for corticosteroid-sparing systemic immunosuppressive agents in patients with inflammatory eye disease [PDF]
Kim Baker+4 more
openalex +1 more source
GLed, a reversible lanthanide‐based GSH sensor that enables real‐time, single‐cell measurement of Gamma–Glutamyl Cysteine Ligase (GCL) activity ‐whose role in human T cells remains unclear‐ is developed. GLed directly links GCL activity to T cell effector functions and reveals its modulation by immunosuppressive drugs, identifying GCL as a critical ...
Francisco Fueyo‐González+9 more
wiley +1 more source
Long-term outcome of autologous haematopoietic stem cell transplantation in patients with systemic sclerosis: a comparison with patients treated with rituximab and with traditional immunosuppressive agents. [PDF]
Del Papa N+13 more
europepmc +1 more source
Review of: Hill RB, Rowlands DT, Rifkind D: Infectious pulmonary disease in patients receiving immunosuppressive therapy for organ transplantation [PDF]
Starzl, TE
core
Predictive factors associated with immunosuppressive agent use in ulcerative colitis: a case–control study [PDF]
Agatha Lau+3 more
openalex +1 more source
Research Progress on Biomaterials with Immunomodulatory Effects in Bone Regeneration
This review highlights recent advanced in immunomodulatory biomaterials for bone repair, focusing on design strategies, immune interactions, and clinical potential. Abstract The immune system plays a pivotal role in bone regeneration, and biomaterials engineered to modulate immune responses present a promising strategy for the treatment of extensive ...
Jianan Li+11 more
wiley +1 more source
Adopting a paradigm shift that transforms a known health hazard as a potential therapeutic asset, a novel therapeutic strategy is set out to investigate for inflammatory conditions by leveraging immunosuppressive properties of UV‐irradiated keratinocytes.
Lu Liu+16 more
wiley +1 more source
Effect of immunosuppressive agents on clinical outcomes in idiopathic membranous nephropathy. [PDF]
Choi JY+9 more
europepmc +1 more source